America Stem Cell Awarded $2.5 Million from the Texas Emerging Technology Fund

ASC's enzyme treatment could potentially transform cord blood stem cell engraftment, accelerate patients' immune system and platelet recovery, reduce opportunistic infections and improve cord blood stem cell transplant patient survival and quality of life.

http://ift.tt/1pMwrM8